• Better life with AmoyDx
    more
  • Better life with AmoyDx
    more
  • AmoyDx won the Second Prize of National Scientific and Technological Progress Award
    more
  • Better life with AmoyDx
    more
Scroll

ABOUT AMOYDX

Amoy Diagnostics Co., Ltd. (AmoyDx) focuses on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS and Super-ARMS technologies, AmoyDx has a market-leading portfolio of molecular diagnostic kits including but not limited to EGFR, RAS, ALK, BRAF, PIK3CA and ROS1 testing kits, which were firstly approved by CFDA and CE certified. 

more
Better Life with AmoyDx

Latest News

Latest News more
14 /Oct

Visit AmoyDx at ESGO 2021 in Prague, Czech Republic

AmoyDx will be exhibiting at ESGO in Prague, Czech Republic from 23 Oct. - 25 Oct. 2021. Please block your calendar and be sure to stop by our booth 6#, 2nd floor, Prague Congress Centre.

19 /Aug

AmoyDx Collaborates with Amgen to Develop Companion Diagnostics for Japan Market

Xiamen, China, Aug 19, 2021 - Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685), an innovative commercial-stage in vitro diagnostic (IVD) company, and Amgen Inc. (NASDAQ: AMGN), announced today that the companies have entered into a strategic collaboratio

17 /Aug

AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as Companion Diagnostic for TEPMETKO® (tepotinib)

TOKYO and XIAMEN, August 17, 2021 (GLOBE NEWSWIRE) -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd. (“AmoyDx”), and Precision Medicine Asia Co., Ltd. (“PREMIA”) today announced that the Ministry of Health, Labour and Welfare (MHLW) has approved the

30 /Jun

AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as Companion Diagnostic for 9 Targeted Therapies for Use in Patients with Advanced Non-Small Cell Lung Cancer

TOKYO and XIAMEN, June 30, 2021 (GLOBE NEWSWIRE) -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd. (“PREMIA”) today announced that the AmoyDx® Pan Lung Cancer PCR Panel (the “AmoyDx® PLC Panel”), an i

more

New Products

new product release

    New Products

    new product release
    • Pan Lung Cancer PCR Panel

    • HRD Focus Panel

    • HANDLE Classic NGS Panel

    • BRCA1 and BRCA2 Gene Mutation Detection Kit

    • PLC Pan Lung Cancer PCR Panel
      01
    • HRD HRD Focus Panel
      02
    • Classic HANDLE Classic NGS Panel
      03
    • BRCA BRCA1 and BRCA2 Gene Mutation Detection Kit
      04
    1. 01
    2. 02
    3. 03
    4. 04
    • Pan Lung Cancer PCR Panel

    • HRD Focus Panel

    • HANDLE Classic NGS Panel

    • BRCA1 and BRCA2 Gene Mutation Detection Kit

    • PLC Pan Lung Cancer PCR Panel
      01
    • HRD HRD Focus Panel
      02
    • Classic HANDLE Classic NGS Panel
      03
    • BRCA BRCA1 and BRCA2 Gene Mutation Detection Kit
      04
    1. 01
    2. 02
    3. 03
    4. 04
    • Pan Lung Cancer PCR Panel

    • HRD Focus Panel

    • HANDLE Classic NGS Panel

    • BRCA1 and BRCA2 Gene Mutation Detection Kit

    • PLC Pan Lung Cancer PCR Panel
      01
    • HRD HRD Focus Panel
      02
    • Classic HANDLE Classic NGS Panel
      03
    • BRCA BRCA1 and BRCA2 Gene Mutation Detection Kit
      04
    1. 01
    2. 02
    3. 03
    4. 04
    • Pan Lung Cancer PCR Panel

    • HRD Focus Panel

    • HANDLE Classic NGS Panel

    • BRCA1 and BRCA2 Gene Mutation Detection Kit

    • PLC Pan Lung Cancer PCR Panel
      01
    • HRD HRD Focus Panel
      02
    • Classic HANDLE Classic NGS Panel
      03
    • BRCA BRCA1 and BRCA2 Gene Mutation Detection Kit
      04
    1. 01
    2. 02
    3. 03
    4. 04
  1. NGS
  2. PCR
  3. FISH
  4. Extraction

ESGO 2021

https://congress.esgo.org/

October 23-25, 2021
meet us

World Conference on Lung Cancer 2020

https://wclc2020.iaslc.org/

January 26 – 29, 2021
  • Stock Info

    Stock info
  • 84.910 +5.21 +6.54%
    Stock code:300685 2021-11-26 15:00:03 Real-time data
  • View details
Inquiry
* Required information
Manage your account info
Change your password